Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
نویسندگان
چکیده
Abstract The PCAWG Consortium has recently released an unprecedented set of tumor whole genome sequence (WGS) data from 2,658 cancer patients across 38 different primary sites1. WGS is able to document the quantity and distribution telomeric repeats2. In one papers analyzing dataset, Sieverling et al.3 confirmed previous data4 indicating that tumors with truncating ATRX or DAXX alterations, referred as ATRX/DAXXtrunc, have aberrant telomere variant repeat (TVR) distribution. By regarding these mutations, vs. TERT modifications (TERTmod; i.e. promoter mutations +/? amplifications structural variations), indicators Alternative Lengthening Telomeres (ALT) telomerase, they built a random forest classifier for ALT-probability, then associated genomic characteristics putative Telomere Maintenance Mechanism (TMM)3. However, we show here equating ATRX/DAXXtrunc TERTmod ALT respectively, results in TMM predictions which correlate poorly assay data. are heterogeneously distributed ALT-positive (ALT+) types, telomerase-positive tumors4. Although strongly TMM, most do not harbor them, making them inadequate basis building large-scale pan-cancer study4–7. Here, provide new analysis data, based on C-circle (CCA)8 available subset tumors4,9,10. We al. score overestimates proportion misclassifies when absent. also some TVR regardless TMM. Finally, propose identify cohort.
منابع مشابه
ATRX represses alternative lengthening of telomeres
The unlimited proliferation of cancer cells requires a mechanism to prevent telomere shortening. Alternative Lengthening of Telomeres (ALT) is an homologous recombination-mediated mechanism of telomere elongation used in tumors, including osteosarcomas, soft tissue sarcoma subtypes, and glial brain tumors. Mutations in the ATRX/DAXX chromatin remodeling complex have been reported in tumors and ...
متن کاملCancer Cells with Alternative Lengthening of Telomeres Do Not Display a General Hypersensitivity to ATR Inhibition
Telomere maintenance is a hallmark of cancer as it provides cancer cells with cellular immortality. A significant fraction of tumors uses the alternative lengthening of telomeres (ALT) pathway to elongate their telomeres and to gain an unlimited proliferation potential. Since the ALT pathway is unique to cancer cells, it represents a potentially valuable, currently unexploited target for anti-c...
متن کاملAlternative lengthening of telomeres in normal mammalian somatic cells.
Some cancers use alternative lengthening of telomeres (ALT), a mechanism whereby new telomeric DNA is synthesized from a DNA template. To determine whether normal mammalian tissues have ALT activity, we generated a mouse strain containing a DNA tag in a single telomere. We found that the tagged telomere was copied by other telomeres in somatic tissues but not the germline. The tagged telomere w...
متن کاملDetection of alternative lengthening of telomeres by telomere quantitative PCR
Alternative lengthening of telomeres (ALT) is one of the two known telomere length maintenance mechanisms that are essential for the unlimited proliferation potential of cancer cells. Existing methods for detecting ALT in tumors require substantial amounts of tumor material and are labor intensive, making it difficult to study prevalence and prognostic significance of ALT in large tumor cohorts...
متن کاملAlternative lengthening of telomeres: remodeling the telomere architecture
To escape from the normal limits on proliferative potential, cancer cells must employ a means to counteract the gradual telomere attrition that accompanies semi-conservative DNA replication. While the majority of human cancers do this by up-regulating telomerase enzyme activity, most of the remainder use a homologous recombination-mediated mechanism of telomere elongation known as alternative l...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Communications
سال: 2021
ISSN: ['2041-1723']
DOI: https://doi.org/10.1038/s41467-021-21794-0